Related references
Note: Only part of the references are listed.Additional hepatic 166Ho-radioembolization in patients with neuroendocrine tumours treated with 177Lu-DOTATATE; a single center, interventional, non-randomized, non-comparative, open label, phase II study (HEPAR PLUS trial)
Arthur J. A. T. Braat et al.
BMC GASTROENTEROLOGY (2018)
Long-Term Toxicity after Transarterial Radioembolization with Yttrium-90 Using Resin Microspheres for Neuroendocrine Tumor Liver Metastases
Yuki Tomozawa et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2018)
Safety and Feasibility of Integrating Yttrium-90 Radioembolization With Capecitabine-Temozolomide for Grade 2 Liver-Dominant Metastatic Neuroendocrine Tumors
Michael C. Soulen et al.
PANCREAS (2018)
Embolotherapy for Neuroendocrine Tumor Liver Metastases: Prognostic Factors for Hepatic Progression-Free Survival and Overall Survival
James X. Chen et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2017)
Tumor Dose Response in Yttrium-90 Resin Microsphere Embolization for Neuroendocrine Liver Metastases: A Tumor-Specific Analysis with Dose Estimation Using SPECT-CT
Orapin Chansanti et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2017)
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
J. Strosberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Selective internal radiation therapy in patients with progressive neuroendocrine liver metastases
Charlotte Ebeling Barbier et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Lung Shunt Fraction prior to Yttrium-90 Radioembolization Predicts Survival in Patients with Neuroendocrine Liver Metastases: Single-Center Prospective Analysis
Johannes M. Ludwig et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2016)
Prospective Longitudinal Quality of Life Assessment in Patients With Neuroendocrine Tumor Liver Metastases Treated With 90Y Radioembolization
Brandon Cramer et al.
CLINICAL NUCLEAR MEDICINE (2016)
Selective Internal Radiation Therapy With Yttrium-90 Glass Microspheres: Biases and Uncertainties in Absorbed Dose Calculations Between Clinical Dosimetry Models
Justin K. Mikell et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study
James C. Yao et al.
LANCET (2016)
Ki67 score as a potential predictor in the selection of liver-directed therapies for metastatic neuroendocrine tumors: a single institutional experience
Smit Singla et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2016)
Radioembolization with yttrium-90 resin microspheres for neuroendocrine tumor liver metastases
Ahmet Peker et al.
DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY (2015)
Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms
M. Heetfeld et al.
ENDOCRINE-RELATED CANCER (2015)
Role of hepatic intra-arterial therapies in metastatic neuroendocrine tumours (NET): guidelines from the NET-Liver-Metastases Consensus Conference
Andrew Kennedy et al.
HPB (2015)
Radioembolization with yttrium-90 resin microspheres for neuroendocrine tumor liver metastases
Ahmet Peker et al.
DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY (2015)
Radioembolization Dosimetry: The Road Ahead
Maarten L. J. Smits et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2015)
The 2010 WHO Classification of Digestive Neuroendocrine Neoplasms: a Critical Appraisal four years after Its Introduction
G. Rindi et al.
ENDOCRINE PATHOLOGY (2014)
99mTc-MAA overestimates the absorbed dose to the lungs in radioembolization: a quantitative evaluation in patients treated with 166Ho-microspheres
Mattijs Elschot et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
The Efficacy of Hepatic 90Y Resin Radioembolization for Metastatic Neuroendocrine Tumors: A Meta-Analysis
Zlatko Devcic et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Recommendations for management of patients with neuroendocrine liver metastases
Andrea Frilling et al.
LANCET ONCOLOGY (2014)
Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
Martyn E. Caplin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Initial Outcome After Selective Intraarterial Radionuclide Therapy with Yttrium-90 Microspheres as Salvage Therapy for Unresectable Metastatic Liver Disease
Cuneyt Turkmen et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2013)
Safety of Repeated Yttrium-90 Radioembolization
Marnix G. E. H. Lam et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2013)
Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept
E. Garin et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Defining predictors for long progression-free survival after radioembolisation of hepatic metastases of neuroendocrine origin
Wieland H. Sommer et al.
EUROPEAN RADIOLOGY (2013)
Radioembolization for Treatment of Liver Metastases From Neuroendocrine Tumors Correlation With Imaging and Biomarkers
Junko Ozao-Choy et al.
PANCREAS (2013)
ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary
Marianne Pavel et al.
NEUROENDOCRINOLOGY (2012)
The Epidemiology of Gastroenteropancreatic Neuroendocrine Tumors
Ben Lawrence et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2011)
Research Reporting Standards for Radioembolization of Hepatic Malignancies
Riad Salem et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2011)
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors.
Eric Raymond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Factors Predicting Response and Survival After Yttrium-90 Radioembolization of Unresectable Neuroendocrine Tumor Liver Metastases A Critical Appraisal of 48 Cases
Akshat Saxena et al.
ANNALS OF SURGERY (2010)
Radioembolization with yttrium microspheres for neuroendocrine tumour liver metastases
C. Q. Cao et al.
BRITISH JOURNAL OF SURGERY (2010)
Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
Riccardo Lencioni et al.
SEMINARS IN LIVER DISEASE (2010)
Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic disease
A. Frilling et al.
BRITISH JOURNAL OF SURGERY (2009)
TREATMENT PARAMETERS AND OUTCOME IN 680 TREATMENTS OF INTERNAL RADIATION WITH RESIN 90Y-MICROSPHERES FOR UNRESECTABLE HEPATIC TUMORS
Andrew S. Kennedy et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres:: Early results in 148 patients
Andrew S. Kennedy et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2008)
Share Paper
